Patty Starkovich

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

M. Mulligan, W. Keitel, Shital M. Patel, 2015, The Journal of infectious diseases.

Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

C. Whitney, J. Nelson, K. Neuzil, 2005, Vaccine.

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

C. Whitney, J. Nelson, K. Neuzil, 2007, Vaccine.

Prospective Assessment of the Effect of Needle Length and Injection Site on the Risk of Local Reactions to the Fifth Diphtheria-Tetanus-Acellular Pertussis Vaccination

J. Nelson, M. Decker, L. Jackson, 2008, Pediatrics.

Prophylaxis With Acetaminophen or Ibuprofen for Prevention of Local Reactions to the Fifth Diphtheria-Tetanus Toxoids-Acellular Pertussis Vaccination: A Randomized, Controlled Trial

J. Nelson, L. Jackson, Onchee Yu, 2006, Pediatrics.

Postpartum Varicella Vaccination: Is the Vaccine Virus Excreted in Breast Milk?

J. Seward, L. Jackson, V. Loparev, 2003, Obstetrics and gynecology.

A Randomized Placebo-Controlled Trial of Acetaminophen for Prevention of Post-Vaccination Fever in Infants

Clara P Domínguez-Islas, J. Nelson, S. Hambidge, 2011, PloS one.